J&A Issued U.S. Patent Covering the Artificial Intelligence Technology of
Flagship DaMi2(TM) AI Analysis Engine
Radical Evolution of Fundamental Genetic Algorithm Produces Unprecedented
Analytical Power for Complex Databases.
OAKTON, Va., Oct. 27 /PRNewswire/ -- Jacobson & Associates, LLC (J&A) today
announced that the U.S. Patent and Trademark Office has issued Patent No.
7,603,325, Concurrent Two-Phase Completion Genetic Algorithm Systems and
Methods. Building upon John Holland's original Artificial Intelligence
architecture, the Genetic Algorithm (GA), J&A's Two-Phase Completion Genetic
Algorithm (2CGA) offers unique innovations which improve performance to the
order of 2,000 times that of current GA's. Claimed innovations of the 2CGA
architecture include:
-- An embedded, functional dominance and abeyance architecture of
n-dimensional polyploidy, improving upon the Hollstein-Holland
Tri-allelic Structure (Hollstein 1971), (Goldberg and Smith 1987).
-- A markedly improved Mutation operator, delivering increased efficacy
of
lost genotype return to population at lower Mutation Operator ratios,
and thereby higher lift without sacrificing stability when employing
more aggressive Crossover Operators.
-- A system architecture which satisfies the yet unmet goals of a
"Competent" GA (Goldberg 2002). Genotype classification to optimal
building blocks and Phenotype optimization are performed
concentrically
in a single "run." Analytical resource focus automatically,
proportionally transitions from Genotype to Phenotype based on optimum
building block identification progress. It can adjust
bi-directionally, allowing for input of dynamic source data feeds
during
an active, unattended analysis.
In practical application, J&A's 2CGA allows effective multi-variable analyses
of 50 - 60 variables (without replacement) simultaneously on a single system,
without the need for pre-processing or mini-runs to pre-select interesting
variables or variable groups (data fields). Using this architecture, multiple
DaMi2 instances may attack a single task and will automatically collaborate to
increase detection speed or surmount higher order tasks more effectively than
standard parallel processing or grid computing. Tremendous, complex
statistical analysis problems may now be practicably addressed without
specialized hardware and large teams of statisticians. This technology is
commercially applicable to enhance precision in predictive analytics and
increase speed of statistical analyses in Epidemiology, Health Risk Reduction,
Insurance, Financial Performance and Investment Portfolio Optimization,
Merchandizing, and Consumer Response. It is equally suited to traditionally
Government/Military applications including threat assessment/detection, total
information awareness, and vocal, optical, and electronic analysis.
"While the envelope for higher capacity in statistical analysis has been
addressed by some brilliant breakthroughs in hardware processing speeds, we
can achieve even more significant gains by infusion of sophisticated but
elegant enrichment in the analytical applications themselves," says David L.
Jacobson, founder and CEO of J&A. "Our focus on expanding the science of
algorithm development itself, without the need for an expensive hardware
footprint, allows smaller teams to attack analysis problems that were
previously cost-prohibitive. Synergy of our technology with recent hardware
innovations will provide exponential gains in analytical capacity."
Patent 7,603,325 is the first issued in a series of four Patents associated
with J&A's unique Intellectual Property and its DaMi2 product line.
About Jacobson & Associates, LLC
Established in 2003, Virginia-based Jacobson & Associates, LLC (J&A) is an
emerging leader in Artificial Intelligence and Predictive Analytics product
development and associated services. J&A offers advanced Artificial
Intelligence (AI) technologies to rapidly detect and identify critical
information within customers' data, with extraordinary speed and precision,
but at significantly lower total cost than alternative solutions. J&A focuses
on the Health & Biosciences, Financial, Merchandising, and Federal Government
Sectors; more specifically large-scale predictive analytics, econometric,
epidemiological, medical surveillance, threat and health assessment, and mass
classification.
www.jacobsonassoc.com
SOURCE Jacobson & Associates, LLC
Jacobson & Associates, LLC, Faith E. Jacobson, +1-703-929-2782,
info@jacobsonassoc.com
